{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T12:30:13Z","timestamp":1724416213220},"reference-count":24,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2010,3,6]],"date-time":"2010-03-06T00:00:00Z","timestamp":1267833600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2010,3,6]],"date-time":"2010-03-06T00:00:00Z","timestamp":1267833600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1111\/j.1365-2133.2010.09751.x","type":"journal-article","created":{"date-parts":[[2010,3,6]],"date-time":"2010-03-06T13:38:33Z","timestamp":1267882713000},"page":"633-637","source":"Crossref","is-referenced-by-count":9,"title":["Refractory aggressive keratoacanthoma centrifugum marginatum of the scalp controlled with the epidermal growth factor receptor inhibitor erlotinib"],"prefix":"10.1093","volume":"163","author":[{"given":"T.K.","family":"Bulj","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.L.","family":"Krunic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.S.","family":"Cetner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.L.","family":"Villano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,3,6]]},"reference":[{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1067\/S0190-9622(03)00454-7","article-title":"Ferguson Smith type multiple keratoacanthomas and a keratoacanthoma centrifugum marginatum in a woman from Japan","volume":"49","author":"Kato","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2340\/00015555-0023","article-title":"A case of multiple keratoacanthomas associated with keratoacanthoma centrifugum marginatum","volume":"86","author":"Gonul","year":"2006","journal-title":"Acta Derm Venereol (Stockh)"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB3|cit3","first-page":"803","article-title":"A case of multiple keratoacanthoma centrifugum marginatum","volume":"30","author":"Mangas","year":"2004","journal-title":"Dermatol Surg"},{"issue":"Suppl. 5","key":"10.1111\/j.1365-2133.2010.09751.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"S218","DOI":"10.1016\/j.jaad.2005.07.023","article-title":"Keratoacanthoma centrifugum marginatum: response to topical 5-fluorouracil","volume":"54","author":"Yuge","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB5|cit5","first-page":"1205","article-title":"Immunohistochemical analysis of EGFR and HER-2 in patients with metastatic squamous cell carcinoma of the skin","volume":"25","author":"Maubec","year":"2005","journal-title":"Anticancer Res"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000051637","article-title":"Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin","volume":"202","author":"Shimizu","year":"2001","journal-title":"Dermatology"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"5253","DOI":"10.1200\/JCO.2006.08.2263","article-title":"Phase II trial of cetuximab in patients with previously treated non-small-cell lung cancer","volume":"24","author":"Hanna","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"5578","DOI":"10.1200\/JCO.2005.07.120","article-title":"Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck","volume":"23","author":"Herbst","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/CCO.0b013e3282f9b575","article-title":"Molecular-targeted therapies in the treatment of squamous cell carcinomas of the head and neck","volume":"20","author":"Le Torneau","year":"2008","journal-title":"Curr Opin Oncol"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1100\/tsw.2008.117","article-title":"EGFR-targeted therapeutics: focus on SCCHN and NSCLC","volume":"8","author":"Sattler","year":"2008","journal-title":"ScientificWorldJournal"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2006.06.7447","article-title":"Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based therapy","volume":"25","author":"Vermorken","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1053\/j.seminoncol.2006.04.002","article-title":"Role of Raf kinase in cancer: therapeutic potential of targeting Raf\/MEK\/ERK signal transduction pathway","volume":"33","author":"Gollob","year":"2006","journal-title":"Semin Oncol"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB13|cit13","first-page":"1","article-title":"Cutaneous reactions to anticancer agents targeting the epidermal growth factor receptor: a dermatology-oncology perspective","volume":"12","author":"Lacouture","year":"2007","journal-title":"Skin Therapy Lett"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.jaad.2006.09.005","article-title":"Cutaneous side effects of epidermal growth factor receptor inhibitors: clinical presentation, pathogenesis, and management","volume":"56","author":"Hu","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1001\/archderm.143.7.889","article-title":"Treatment of recurrent squamous cell carcinoma of the skin with cetuximab","volume":"143","author":"Bauman","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1097\/CAD.0b013e32809ef9e0","article-title":"Cutaneous squamous cell carcinoma responding serially to single-agent cetuximab","volume":"18","author":"Suen","year":"2007","journal-title":"Anticancer Drugs"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1610-0387.2008.06861.x","article-title":"Combination of EGFR blocker and a COX-2 inhibitor for the treatment of advanced cutaneous squamous cell carcinoma","volume":"6","author":"Jalili","year":"2008","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"7086","DOI":"10.1158\/1078-0432.CCR-07-1370","article-title":"Pilot study of neoadjuvant treatment with erlotinib in nonmetastatic head and neck squamous cell carcinoma","volume":"13","author":"Thomas","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB19|cit19","first-page":"581","article-title":"Erlotinib-responsive actinic keratoses","volume":"18","author":"Hermanns","year":"2007","journal-title":"Oncol Rep"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.humpath.2007.07.004","article-title":"Epidermal growth factor receptor: a novel biomarker for aggressive head and neck cutaneous squamous cell carcinoma","volume":"39","author":"Ch\u2019ng","year":"2008","journal-title":"Hum Pathol"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/cncr.23557","article-title":"Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma","volume":"113","author":"Muller","year":"2008","journal-title":"Cancer"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1600-0560.1992.tb01561.x","article-title":"Abnormal expression of epidermal growth factor receptor in cutaneous epithelial tumors","volume":"19","author":"Groves","year":"1992","journal-title":"J Cutan Pathol"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.jaad.2008.10.043","article-title":"The histologic spectrum of epithelial neoplasms induced by sorafenib","volume":"61","author":"Kwon","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2010.09751.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1200\/JCO.2009.23.4823","article-title":"Keratoacanthomas and squamous cell carcinomas in patients receiving sorafenib","volume":"27","author":"Arnault","year":"2009","journal-title":"J Clin Oncol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.09751.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2010.09751.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2010.09751.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T19:51:52Z","timestamp":1685476312000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/163\/3\/633\/6642622"}},"subtitle":["Erlotinib for refractory KCM of the scalp"],"short-title":[],"issued":{"date-parts":[[2010,3,6]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010,9]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2010.09751.x","archive":["Portico"],"relation":{},"ISSN":["0007-0963"],"issn-type":[{"value":"0007-0963","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3,6]]}}}